
zzso zzso is recommended as a treatment of zzso zzso zzso in children, although published data to support this approach are zzso The authors sought to determine the efficacy of zzso zzso for pediatric zzso 

The authors reviewed all children treated with zzso zzso for zzso at two zzso children's hospitals, assessing outcome by zzso fluid zzso zzso zzso examination, and overall survival zzso 

Fifteen children with zzso evidenced by zzso cells in the zzso fluid zzso age zzso years; five zzso one zzso zzso one glioblastoma, one zzso one zzso two zzso one zzso lymphoma, two acute zzso zzso and one acute zzso zzso were treated with zzso zzso at 5 to zzso zzso per dose for two to seven zzso Five children received zzso zzso zzso 12 received simultaneous systemic or other zzso chemotherapy, or zzso Four children experienced clearance of zzso cells from the spinal fluid, but this response was sustained in only zzso All four children with zzso response received concurrent zzso chemotherapy, or zzso No patients showed partial or complete response on zzso Only one child had improvement on the zzso zzso six were unchanged and eight had worsening zzso zzso Median survival was zzso weeks, with a zzso overall survival rate of zzso zzso error zzso 

The zzso outcomes observed suggest that zzso zzso adds little to combination therapy for pediatric zzso 

